Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of LRRC4 mRNA | CTD | PMID:22217510 | 17beta-estradiol | increases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Estradiol results in increased expression of LRRC4 mRNA | CTD | PMID:31614463 | 17beta-estradiol | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of LRRC4 mRNA | CTD | PMID:36828454 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC4 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC4 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Lrrc4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LRRC4 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lrrc4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LRRC4 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Lrrc4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LRRC4 mRNA | CTD | PMID:21354282 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Lrrc4 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of LRRC4 promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRRC4 mRNA | CTD | PMID:36041667 | all-trans-retinoic acid | multiple interactions | ISO | Lrrc4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC4 mRNA | CTD | PMID:36189433 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of LRRC4 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | increases methylation | ISO | LRRC4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LRRC4 3' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LRRC4 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of LRRC4 mRNA | CTD | PMID:36828454 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRRC4 mRNA | CTD | PMID:36041667 | bisphenol A | increases expression | ISO | Lrrc4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LRRC4 mRNA | CTD | PMID:30951980 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRRC4 mRNA | CTD | PMID:36041667 | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of LRRC4 mRNA | CTD | PMID:32479839 | carbamazepine | affects expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of LRRC4 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Lrrc4 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of LRRC4 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LRRC4 gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | Lrrc4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC4 gene | CTD | PMID:20938992 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of LRRC4 mRNA | CTD | PMID:26577399 | dimethyl sulfoxide | affects expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide affects the expression of LRRC4 mRNA | CTD | PMID:24834073 | dioxygen | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of LRRC4 mRNA | CTD | PMID:26516004 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LRRC4 mRNA | CTD | PMID:33729688 | dorsomorphin | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of LRRC4 mRNA | CTD | PMID:29391264 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of LRRC4 mRNA | CTD | PMID:31464424 | entinostat | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC4 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | entinostat results in decreased expression of LRRC4 mRNA | CTD | PMID:26272509 | folic acid | multiple interactions | ISO | Lrrc4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC4 gene | CTD | PMID:20938992 | folic acid | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of LRRC4 mRNA | CTD | PMID:21867686 | hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Arbutin results in decreased expression of LRRC4 mRNA | CTD | PMID:17103032 | kojic acid | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | kojic acid results in decreased expression of LRRC4 mRNA | CTD | PMID:16595896 | L-methionine | multiple interactions | ISO | Lrrc4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC4 gene | CTD | PMID:20938992 | lipopolysaccharide | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of LRRC4 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRC4 mRNA | CTD | PMID:35811015 | mono(2-ethylhexyl) phthalate | affects expression | ISO | Lrrc4 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate affects the expression of LRRC4 mRNA | CTD | PMID:21195148 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Lrrc4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRC4 mRNA | CTD | PMID:36189433 | Monobutylphthalate | affects expression | ISO | Lrrc4 (Mus musculus) | 6480464 | monobutyl phthalate affects the expression of LRRC4 mRNA | CTD | PMID:21195148 | potassium dichromate | increases expression | ISO | Lrrc4 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of LRRC4 mRNA | CTD | PMID:23608068 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRC4 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | affects expression | ISO | LRRC4 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of LRRC4 mRNA | CTD | PMID:34032870 | sunitinib | increases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of LRRC4 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LRRC4 mRNA | CTD | PMID:32741896 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of LRRC4 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of LRRC4 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC4 mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of LRRC4 mRNA | CTD | PMID:30510588 | trimellitic anhydride | decreases expression | ISO | Lrrc4 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of LRRC4 mRNA | CTD | PMID:19042947 | valproic acid | affects expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LRRC4 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of LRRC4 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | LRRC4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC4 mRNA | CTD | PMID:27188386 | zearalenone | decreases expression | ISO | LRRC4 (Homo sapiens) | 6480464 | Zearalenone results in decreased expression of LRRC4 mRNA | CTD | PMID:36828454 | |